Parkinson's Research Update 2017

A series of talks from the 2017 OPDC Participants' Day, September 4th 2017, Jury's Inn, Oxford

OPDC Scientists and Clinicians talk about different aspects of our research into Parkinson's. Talks covered links between Parkinson's and sleep, development of wearable technology and drug discovery/repurposing.

OPDC-inspired Parkinson's trials coming soon

OPDC clinical lead, Dr Michele Hu, on how we are working with our cohort and how we hope to repurpose drugs, already approved for other conditions, to improve not only the symptoms of people with Parkinson's, but also hope to slow down the progression of the condition.

OPDC Highlights 2017

A short video highlighting the key research being carried out at OPDC. Featuring OPDC researchers discussing work on drug discovery/repurposing, sleep disorders, wearable technology and stem cell techniques to gorw neurons and microglia in the lab.

 

Impulse control disorder in Parkinson’s

Dr Mark Kelly's research has been mainly looking at some of the current medications available for Parkinson's. Here he discusses a side-effect of one of those medications called impulse control disorder.

 

Rapid eye movement sleep behavior disorder (RBD): a window into early Parkinson’s

Dr Tom Barber on his research into REM sleep behaviour disorder and how this can give us insights into early Parkinson's.

 

What is the OPDC doing to improve your sleep?

We know that sleep is important for day-to-day activities, memory and attention. Dr Christine Lo is working at the Oxford Parkinson's Disease Centre on a project to look at using wearable devices to study sleep in detail in REM-sleep Behaviour Disorder and Parkinson's.

 

Could inflammation be important to Parkinson’s?

Dr Sally Cowley works at OPDC growing neurons and other important cells from skin samples donated in biopsies from members of our cohort. Here she discusses her work on microglia, the vacuum cleaners of the brain.

 

Novel Parkinson’s therapies in the Oxford Discovery pipeline

Professor Richard Wade-Martins discusses how dopamine neurons grown in a dish in our labs are helping us to understand of these cells are affected in Parkinson's.